Eton Pharmaceuticals, Inc. Share Price
ETONEton Pharmaceuticals, Inc. Stock Performance
Open $27.20 | Prev. Close $27.30 | Circuit Range N/A |
Day Range $26.83 - $27.41 | Year Range $13.09 - $35.58 | Volume 14,057 |
Average Traded $27.29 |
Eton Pharmaceuticals, Inc. Share Price Chart
About Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Eton Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
02-Jun-26 | $28.35 | $27.37 | -4.53% |
01-Jun-26 | $30.30 | $28.67 | -5.33% |
29-May-26 | $31.25 | $30.29 | -4.79% |
28-May-26 | $31.80 | $31.81 | -1.68% |
27-May-26 | $30.65 | $32.35 | +3.47% |
26-May-26 | $31.64 | $31.27 | -4.17% |
22-May-26 | $34.34 | $32.63 | -6.88% |